Study of Pomalidomide in Anal Cancer Precursors (SPACE): a Phase 2 Study of Immunomodulation in People With Persistent HPV-associated High Grade Squamous Intraepithelial Lesions
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 13 Jun 2018
At a glance
- Drugs Pomalidomide (Primary)
- Indications Cervical intraepithelial neoplasia
- Focus Therapeutic Use
- Acronyms SPACE
- 06 Jun 2018 Status changed from recruiting to active, no longer recruiting.
- 22 Jun 2017 Status changed from not yet recruiting to recruiting.
- 20 Apr 2017 New trial record